2,435.00
-21.00
(-0.86%)
At close: January 30 at 5:24:48 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
41,606.00
4,315.00
28,586.00
-8,819.00
19,105.00
Investing Cash Flow
-9,788.00
-5,843.00
-3,784.00
-61,050.00
-13,127.00
Financing Cash Flow
-13,084.00
22,678.00
-9,343.00
18,593.00
23,364.00
End Cash Position
71,337.00
55,641.00
34,258.00
18,587.00
70,197.00
Capital Expenditure
-9,790.00
-5,850.00
-3,784.00
-3,730.00
-5,488.00
Issuance of Capital Stock
--
--
--
--
24,895.00
Issuance of Debt
20,000.00
--
--
20,000.00
--
Repayment of Debt
-972.00
-18,257.00
-3,726.00
-1,426.00
-1,595.00
Free Cash Flow
31,816.00
-1,535.00
24,802.00
-12,549.00
13,617.00
12/31/2020 - 8/31/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
REKA.TA Rekah Pharmaceutical Industry Ltd.
1,344.00
-2.68%
SEMG.TA Seach Medical Group Ltd
300.70
+0.77%
INCR.TA InterCure Ltd.
585.00
-3.23%
MOB.ST Moberg Pharma AB (publ)
9.56
+2.19%
INCR InterCure Ltd.
1.6699
-0.60%
TEVA.TA Teva Pharmaceutical Industries Limited
6,400.00
-5.67%
RDHL RedHill Biopharma Ltd.
5.93
-2.15%
PRGO Perrigo Company plc
24.93
+1.05%
TAK Takeda Pharmaceutical Company Limited
13.70
+2.93%
TEVA Teva Pharmaceutical Industries Limited
17.84
-3.78%